Clinic
Monte Bello Medical, LLC
Monte Bello Medical, LLC was paid $72K by Medicaid between Oct 2023 and Dec 2023, across 11 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 34% of everything it billed.
33Billing provider infoMONTE BELLO MEDICAL, LLC
LAS CRUCES, NM 88011
LAS CRUCES, NM 88011
33aNPI1972226132assigned 09/22/2022
33bProvider typeOccupational Medicine Clinic/Center
28Total paid$72K
24GClaims815
24DCodes billed11
24AFirst – last monthOct 2023 – Dec 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 815 | $72K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 34% | 166 | 158 | $25K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 22% | 86 | 86 | $16K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 72 | 69 | $11K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.9% | 69 | 64 | $7K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.9% | 42 | 42 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.3% | 132 | 127 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.2% | 101 | 95 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 44 | 42 | $107.55 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 32 | 30 | $72.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 57 | 56 | $71.88 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 14 | 14 | $2.37 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDELGADO, YOLIE (DIRECTOR OF OPERATIONS/OWNER)